11 research outputs found
The Impact of Nursing Care in the Intensive Care Unit
As the population ages, the number of patients with more than one chronic disease increases, leading to a greater need for medical care. As a result, the demand for emergency and intensive care in recent years has become increasingly critical. It is advanced practice nurses who play a key role in patient care, and the drive to strengthen the workforce necessitates an increase in their involvement. The independence of advanced practice nurses and their impact on patient outcomes after critical care are of interest.Β The important role of nurses in the provision of health care has recently been recognized. Critical care needs inter-professional teams that provide collaborative health care, which includes the need for trained nurses. Expert and specialized care for the most seriously ill or injured patients in intensive care units (ICUs) and hospitals is provided by intensive care nurses. Working as part of a multidisciplinary team, they are experienced professionals who are highly skilled and safety-critical.Β The greatest responsibility for the care and treatment of patients in a critical or unstable clinical situation in the intensive care unit rests with the nurse. Her primary activities are the management and coordination of nursing care through assessments, therapies, and critical interventions. Based on the best available scientific evidence, clinical experience, and patient preferences, the nurse makes important clinical decisions in the intensive care unit
Tumor Necrosis Factor - alpha in Clinical Manifestation of Paroxysmal Atrial Fibrillation
ΠΡΠ²Π΅Π΄Π΅Π½ΠΈΠ΅: ΠΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎΡΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅ (ΠΠ) Π΅ Π½Π°ΠΉ-ΡΠ΅ΡΡΠ°ΡΠ° Π°ΡΠΈΡΠΌΠΈΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ½Π°ΡΠ° ΠΏΡΠ°ΠΊΡΠΈΠΊΠ°. ΠΡΠ΅ ΠΏΠΎΠ²Π΅ΡΠ΅ Π΄Π°Π½Π½ΠΈ ΡΠ΅ Π½Π°ΡΡΡΠΏΠ²Π°Ρ Π·Π° ΡΡΠ°ΡΡΠΈΠ΅ΡΠΎ Π½Π° ΡΠΈΡΠΎΠΊΠΈΠ½ΠΈΡΠ΅ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°ΡΠ° Π½Π° Π°ΡΠΈΡΠΌΠΈΡΡΠ°, ΠΊΠ°ΡΠΎ ΠΎΠ±Π΅ΠΊΡ Π½Π° ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½Π΅ Π΄ΠΎ ΠΌΠΎΠΌΠ΅Π½ΡΠ° ΡΠ° ΠΏΡΠ΅Π΄ΠΈ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΠ°ΡΠ°ΡΠ° ΠΈ ΠΏΠ΅ΡΠΌΠ°Π½Π΅Π½ΡΠ½Π°ΡΠ° ΡΠΎΡΠΌΠ° Π½Π° ΡΠΈΡΡΠΌΠ½ΠΎΡΠΎ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅.Π¦Π΅Π»: ΠΠ° ΡΠ΅ ΠΏΠΎΡΡΡΡΡΡ ΠΏΡΠΎΠΌΠ΅Π½ΠΈ Π² ΠΏΠ»Π°Π·ΠΌΠ΅Π½ΠΈΡΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π½Π° TNF-Ξ±, ΡΠ²ΡΡΠ·Π°Π½ΠΈ Ρ ΠΈΠ·ΡΠ²Π°ΡΠ° Π½Π° ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎΡΠΎ ΠΏΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅ (ΠΠΠ).ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈ: ΠΠ»Π°Π·ΠΌΠ΅Π½ΠΈΡΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π½Π° TNF-Ξ± Π±ΡΡ
Π° ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈ ΡΡΠΈΠΊΡΠ°ΡΠ½ΠΎ ΠΏΡΠΈ 51 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ (26 ΠΌΡΠΆΠ΅ ΠΈ 25 ΠΆΠ΅Π½ΠΈ; ΡΡΠ΅Π΄Π½Π° Π²ΡΠ·ΡΠ°ΡΡ 59.84 1.60 Π³) Ρ ΠΠΠ, a ΠΈΠΌΠ΅Π½Π½ΠΎ: Π½Π΅Π·Π°Π±Π°Π²Π½ΠΎ ΡΠ»Π΅Π΄ Ρ
ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡΡΠ° ΠΈΠΌ (Ρ.Π΅. ΠΏΠΎ Π²ΡΠ΅ΠΌΠ΅ Π½Π° ΡΠΈΡΡΠΌΠ½ΠΎΡΠΎ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅), 24 ΡΠ°ΡΠ° ΠΈ 28 Π΄Π½ΠΈ ΡΠ»Π΅Π΄ Π²ΡΠ·ΡΡΠ°Π½ΠΎΠ²ΡΠ²Π°Π½Π΅ Π½Π° ΡΠΈΠ½ΡΡΠΎΠ² ΡΠΈΡΡΠΌ. ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡ Π±Π΅ΡΠ΅ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ Π΅Π΄Π½ΠΎΠΊΡΠ°ΡΠ½ΠΎ ΠΏΡΠΈ 52 ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈ (26 ΠΌΡΠΆΠ΅ ΠΈ 26 ΠΆΠ΅Π½ΠΈ; ΡΡΠ΅Π΄Π½Π° Π²ΡΠ·ΡΠ°ΡΡ 59.50 1.46 Π³.) Π±Π΅Π· Π°Π½Π°ΠΌΠ½Π΅ΡΡΠΈΡΠ½ΠΈ ΠΈΠ»ΠΈ Π΅Π»Π΅ΠΊΡΡΠΎΠΊΠ°ΡΠ΄ΠΈΠΎΠ³ΡΠ°ΡΡΠΊΠΈ Π΄Π°Π½Π½ΠΈ Π·Π° ΠΠ Π΄ΠΎ ΠΌΠΎΠΌΠ΅Π½ΡΠ°. ΠΠ»Π°Π·ΠΌΠ΅Π½ΠΈΡΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π½Π° TNF-Ξ± Π±ΡΡ
Π° ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈ Ρ ELISA ΠΊΠΈΡ (Elabscience Biotechnology Co., Ltd, China). Π‘ΠΈΠ½ΡΡΠΎΠ² ΡΠΈΡΡΠΌ Π±Π΅ Π²ΡΠ·ΡΡΠ°Π½ΠΎΠ²Π΅Π½ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½ΡΠΎΠ·Π½ΠΎ Ρ propafenone.Π Π΅Π·ΡΠ»ΡΠ°ΡΠΈ: ΠΡΠΈ ΠΏΠΎΡΡΡΠΏΠ²Π°Π½Π΅ Π½Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ Π² ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ΡΠΎ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈΡΠ΅ Π½Π° TNF-Ξ± Π±ΡΡ
Π° ΠΏΠΎΠ²ΠΈΡΠ΅Π½ΠΈ ΡΠΏΡΡΠΌΠΎ ΡΠ΅Π·ΠΈ Π½Π° ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΠ΅ (15.06 0.81 vs 8.20 0.29 pg/mL, p<0.001). ΠΠ²Π°Π΄Π΅ΡΠ΅Ρ ΠΈ ΡΠ΅ΡΠΈΡΠΈ ΡΠ°ΡΠ° ΡΠ»Π΅Π΄ Π²ΡΠ·ΡΡΠ°Π½ΠΎΠ²ΡΠ²Π°Π½Π΅ Π½Π° ΡΠΈΠ½ΡΡΠΎΠ² ΡΠΈΡΡΠΌ ΠΏΡΠΎΠΌΠ΅Π½ΠΈΡΠ΅ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΠ°Ρ
Π° (13.09 0.70 vs 8.20 0.29 pg/mL, p<0.001). ΠΠ° Π΄Π²Π°Π΄Π΅ΡΠ΅Ρ ΠΈ ΠΎΡΠΌΠΈΡ Π΄Π΅Π½ Π»ΠΈΠΏΡΠ²Π°ΡΠ΅ Π·Π½Π°ΡΠΈΠΌΠ° ΡΠ°Π·Π»ΠΈΠΊΠ° (9.21 0.54 vs 8.20 0.29 pg/mL, p=0.10).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅: ΠΡΠΈ ΠΠΠ ΡΠ΅ Π½Π°Π±Π»ΡΠ΄Π°Π²Π°Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ½ΠΈ ΠΏΡΠΎΠΌΠ΅Π½ΠΈ Π² ΠΏΠ»Π°Π·ΠΌΠ΅Π½ΠΈΡΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π½Π° TNF-Ξ±. Π’Π΅ ΡΠ° Π·Π½Π°ΡΠΈΠΌΠΎ ΠΏΠΎΠ²ΠΈΡΠ΅Π½ΠΈ ΠΏΠΎ Π²ΡΠ΅ΠΌΠ΅ Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ½Π°ΡΠ° ΠΈΠ·ΡΠ²Π° Π½Π° ΡΠΈΡΡΠΌΠ½ΠΎΡΠΎ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅. Π‘Π»Π΅Π΄ Π²ΡΠ·ΡΡΠ°Π½ΠΎΠ²ΡΠ²Π°Π½Π΅ Π½Π° ΡΠΈΠ½ΡΡΠΎΠ² ΡΠΈΡΡΠΌ ΡΠ΅ ΡΠ΅ Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·ΠΈΡΠ°Ρ Π±Π°Π²Π½ΠΎ Π²ΡΠ² Π²ΡΠ΅ΠΌΠ΅ΡΠΎ. Π‘ΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΈΡΡ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ Π½Π° ΡΡΡΠ°Π½ΠΎΠ²Π΅Π½ΠΈΡΠ΅ ΠΎΡΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΡ Π΄Π°Π²Π°Ρ ΡΠ΅ΡΠΈΠΎΠ·Π½ΠΎ ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠ΅ Π΄Π° ΡΠ΅ ΠΏΡΠΈΠ΅ΠΌΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ½Π°ΡΠ° ΠΈΠΌ Π·Π½Π°ΡΠΈΠΌΠΎΡΡ Π·Π° ΠΈΠ·ΡΠ²Π°ΡΠ° Π½Π° Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½Π΅ΡΠΎ.Introduction: Atrial fibrillation is the most common arrhythmia in clinical practice. There has been a growing body of evidence in recent years of the role of inflammatory cytokines in the pathogenesis of the rhythm disorder, although the studies have been predominantly in the field of persistent and permanent atrial fibrillation. Aim: To find changes in plasma concentrations of TNF-Ξ±, concerning the clinical manifestation of paroxysmal atrial fibrillation. Materials and Methods: Plasma concentrations of IL-6 were measured three times in 51 patients (26 men and 25 women; mean age 59.84 1.60 yrs) with paroxysmal atrial fibrillation: once immediately after hospitalization of these patients (that is, during the rhythm disorder episode at baseline), then at 24 hours and finally 28 days after restoration of sinus rhythm. The plasma concentration was measured only once in the control group of 52 control subjects (26 men, 26 women; mean age 59.50 1.46 yrs). We used ELISA kit to determine the IL-6 concentrations. The sinus rhythm was restored with propafenone for all patients. Results: Baseline plasma concentrations of IL-6 were higher than those of controls (15.06.38 0.81 vs 8.20 0.29 pg/mL, p<0.001). The difference was retained for 24 hours after sinus rhythm restoration of (13.09 0.70 vs 8.20 0.29 pg/mL, p<0.001). At 28 days there was no statistically significant difference between patients and controls (9.21 0.54 vs 8.20 0.29 pg/mL, p=0.10). Conclusion: Dynamic changes of TNF-Ξ± plasma concentrations were established in paroxysmal atrial fibrillation. The cytokine levels were significantly elevated during the clinical manifestation of the arrhythmia. They decreased slowly after restoration of sinus rhythm. The changes we found provide a strong rationale to suggest that they are most likely relevant to the clinical manifestaton of paroxysmal atrial fibrillation
Interleukin response in cardiovascular diseases: an overview
Interleukins are important modulators of the immune response in the human body, which inevitably makes them participants in the intimate mechanisms of various diseases. Cardiovascular morbidity and mortality is high in the world as a whole, despite the ongoing primary and secondary prevention. Therefore their pathogenetic mechanisms are of significant research and clinical interest. A number of studies demonstrated changes in the interleukin status of patients with coronary heart disease, heart failure, some cardiomyopathies and rhythm conduction disorders. Significantly altered levels of basic for the immunity pro-inflammatory and anti-inflammatory cytokines were found. It was even proven, that some of them have predictive value for the manifestation of certain diseases. All this is a reason to allow interleukins to take part in the intimate mechanisms of cardiovascular diseases and consider the place of interleukin blockers in the treatment of these diseases
Dynamics of oxidative status in patients with paroxysmal atrial fibrillation
Introduction: Studies have established oxidative disorders in persistent and permanent atrial fibrillation. Our aim was to investigate oxidative status still in the early hours of paroxysmal atrial fibrillation (PAF) and monitor its changes after sinus rhythm (SR) restoration. Material and Methods: Levels of malondialdehyde and total glutathione were determined in plasma (Pl-MDA; Pl-GSH) and erythrocytes (Er-MDA; Er-GSH) together with erythrocyte glutathione peroxidase activity (GSH-Px) in 51 patients (59.84Β±1.6 years, 26 males). Markers were investigated upon hospital admission, 24 hours and 28 days after SR restoration. They were also determined in 52 healthy subjects (59.50Β±1.46 years, 26 males). Results: Mean AF duration prior to hospitalization was 8.14Β±0.76 hours. Upon admission, Pl-MDA and Er-MDA were significantly increased (p0.05). Conclusion: Disorder of oxidative status is detected in the early hours of PAF, which persists after SR restoration. Oxidative balance is restored slowly with time. This specific dynamics of oxidative status is most likely related to AF clinical course, namely to its manifestation and recurrences
Π€Π°ΠΊΡΠΎΡΠΈ, Π²Π»ΠΈΡΠ΅ΡΠΈ Π²ΡΡΡ Ρ Π²Π°ΡΠΈΠ°Π±ΠΈΠ»Π½ΠΎΡΡΡΠ° Π½Π° ΡΡΡΠ΄Π΅ΡΠ½Π°ΡΠ° ΡΠ΅ΡΡΠΎΡΠ°
The heart rate is individual for each person and it is influenced by various factors that lead to its increase or decrease. Good cardiac function is a prerequisite for a healthy life, and heart rate variability (HRV) analysis is a powerful tool for assessing the autonomic nervous system (ANS), in which the sympathetic and parasympathetic systems interact to regulate cardiac function of the vascular system. A high HRV is associated with a good state of health, while a low HRV is associated not only with pathological conditions in the activity of the cardiovascular system, but also with a number of other factors, such as: overweight, type 2 diabetes, stress and others. Tracking HRV over time and matching segments of data related to specific activities or life events can provide unique information about a person's physical and psychological health. On the basis of the obtained results, it can be concluded that the indices of HRV can be used as non-specific indicators of the impact of factors of a different nature on the human body.ΠΠ°ΡΡΠ½ΠΎΡΠΎ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½Π΅ Π΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΊΠ°ΡΠΎ ΡΠ°ΡΡ ΠΎΡ ΠΏΡΠΎΠ΅ΠΊΡΠ° βΠΠ·ΡΠ»Π΅Π΄Π²Π°Π½Π΅ Π½Π° ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ΡΠΎ Π½Π° Π½ΠΎΠ²ΠΈ ΠΌΠ°ΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈ Π·Π° Π°Π½Π°Π»ΠΈΠ· Π½Π° ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΠΈ Π΄Π°Π½Π½ΠΈβ β ΠΠ-06-Π22/5 ΠΎΡ 07.12.2018 Π³., ΡΠΈΠ½Π°Π½ΡΠΈΡΠ°Π½ ΠΎΡ Π€ΠΎΠ½Π΄ βΠΠ°ΡΡΠ½ΠΈ ΠΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈΡβ
Early Deviations in the Coagulation and Fibrinolytic System in Paroxysmal Atrial Fibrillation // ΠΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΏΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅ β ΡΠ°Π½Π½ΠΈ ΠΎΡΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΡ Π² ΠΊΠΎΠ°Π³ΡΠ»Π°ΡΠΈΠΎΠ½Π½Π° ΠΈ ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ»ΠΈΡΠΈΡΠ½Π° ΡΠΈΡΡΠ΅ΠΌΠ°
This thesis presents for the first time convincing clinical and laboratory data for the development of hypercoagulability in the first 24 hours of paroxysmal atrial fibrillation caused by significant deviations in the coagulation and fibrinolytic system. Brief (β€24 hours) episodes of the disease are clearly defined as a prothrombotic state, even in low-risk thromboembolic characteristics of patients (CHA2DS2-VASc score = 0 in men/1 in women). Episode duration affects the established haemostatic deviations. The presented dissertation has not only original scientific value but also clearly outlines clinical applications of the results. It shows that FXIa and FXIIa are more promising targets for effective and safer anticoagulation than currently established. It indicates the need for post-procedural anticoagulation even after currently considered lowest risk episodes of non-valvular paroxysmal atrial fibrillation (β€ 24 hours and CHA2DS2-VASc score = 0 in men/1 in women). It outlines the first 6 hours of the disease as having a lower periprocedural thromboembolic risk. It outlines possibilities for clinical application of some haemostatic indicators beyond haemostatic assessment, namely, the possibility of predicting manifestation of paroxysmal atrial fibrillation by plasminogen plasma activity and t-PA plasma levels and resulting ischemic stroke complications by TF, FVIII and vitronectin plasma levels.Π Π½Π°ΡΡΠΎΡΡΠΈΡ Π΄ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΎΠ½Π΅Π½ ΡΡΡΠ΄ Π·Π° ΠΏΡΡΠ²ΠΈ ΠΏΡΡ ΡΠ° ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π΅Π½ΠΈ ΡΠ±Π΅Π΄ΠΈΡΠ΅Π»Π½ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΈ Π΄Π°Π½Π½ΠΈ Π·Π° ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π° Ρ
ΠΈΠΏΠ΅ΡΠΊΠΎΠ°Π³ΡΠ»Π°Π±ΠΈΠ»ΠΈΡΠ΅Ρ Π² ΠΏΡΡΠ²ΠΈΡΠ΅ 24 ΡΠ°ΡΠ° Π½Π° ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΏΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅, ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ Π½Π° Π·Π½Π°ΡΠΈΠΌΠΈ ΠΎΡΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΡ Π² ΠΊΠΎΠ°Π³ΡΠ»Π°ΡΠΈΠΎΠ½Π½Π° ΠΈ ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ»ΠΈΡΠΈΡΠ½Π° ΡΠΈΡΡΠ΅ΠΌΠ°. ΠΡΠ°ΡΠΊΠΈΡΠ΅ (β€24 ΡΠ°ΡΠ°) Π΅ΠΏΠΈΠ·ΠΎΠ΄ΠΈ Π½Π° Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½Π΅ΡΠΎ ΡΠ° ΡΡΠ½ΠΎ ΠΎΡΠ΅ΡΡΠ°Π½ΠΈ ΠΊΠ°ΡΠΎ ΠΏΡΠΎΡΡΠΎΠΌΠ±ΠΎΠ·Π½ΠΎ ΡΡΡΡΠΎΡΠ½ΠΈΠ΅, Π΄ΠΎΡΠΈ ΠΏΡΠΈ Π½ΠΈΡΠΊΠΎΡΠΈΡΠΊΠΎΠ²Π° ΡΡΠΎΠΌΠ±ΠΎΠ΅ΠΌΠ±ΠΎΠ»ΠΈΡΠ½Π° Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° Π½Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ (CHA2DS2-VASc score = 0 ΠΏΡΠΈ ΠΌΡΠΆΠ΅ ΠΈΠ»ΠΈ 1 ΠΏΡΠΈ ΠΆΠ΅Π½ΠΈ). ΠΠ°Π²Π½ΠΎΡΡΡΠ° Π½Π° Π΅ΠΏΠΈΠ·ΠΎΠ΄Π° ΠΎΠΊΠ°Π·Π²Π° Π΅ΡΠ΅ΠΊΡ Π²ΡΡΡ
Ρ ΡΡΡΠ°Π½ΠΎΠ²Π΅Π½ΠΈΡΠ΅ Ρ
Π΅ΠΌΠΎΡΡΠ°Π·Π½ΠΈ ΠΎΡΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΡ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π΅Π½ΠΈΡΡ Π΄ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΎΠ½Π΅Π½ ΡΡΡΠ΄ ΠΈΠΌΠ° Π½Π΅ ΡΠ°ΠΌΠΎ ΠΎΡΠΈΠ³ΠΈΠ½Π°Π»Π½Π° Π½Π°ΡΡΠ½Π° ΡΡΠΎΠΉΠ½ΠΎΡΡ, Π½ΠΎ ΠΎΡΠ΅ΡΡΠ°Π²Π° ΡΡΠ½ΠΎ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ½ΠΎΡΠΎ ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ Π½Π° ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈ. ΠΠΎΠΊΠ°Π·Π²Π° FXIΠ° ΠΈ FXIIΠ° ΠΊΠ°ΡΠΎ ΠΎΠ±Π΅ΡΠ°Π²Π°ΡΠΈ ΡΠ΅Π»ΠΈ Π·Π° Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½Π° ΠΈ ΠΏΠΎ-Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½Π° Π°Π½ΡΠΈΠΊΠΎΠ°Π³ΡΠ»Π°ΡΠΈΡ ΡΡΠ°Π²Π½Π΅Π½ΠΎ Ρ ΡΡΠ²ΡΡΠ΄Π΅Π½Π°ΡΠ° ΠΊΡΠΌ ΠΌΠΎΠΌΠ΅Π½ΡΠ°. ΠΠΎΠΊΠ°Π·Π²Π° Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡ ΠΎΡ ΠΏΠΎΡΡΠΏΡΠΎΡΠ΅Π΄ΡΡΠ½Π° Π°Π½ΡΠΈΠΊΠΎΠ°Π³ΡΠ»Π°ΡΠΈΡ Π΄ΠΎΡΠΈ ΡΠ»Π΅Π΄ ΡΡΠΈΡΠ°Π½ΠΈΡΠ΅ ΠΊΡΠΌ ΠΌΠΎΠΌΠ΅Π½ΡΠ° Π½Π°ΠΉ-Π½ΠΈΡΠΊΠΎΡΠΈΡΠΊΠΎΠ²ΠΈ Π΅ΠΏΠΈΠ·ΠΎΠ΄ΠΈ Π½Π° Π½Π΅ΠΊΠ»Π°ΠΏΠ½ΠΎ ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΏΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅ (Π΄Π°Π²Π½ΠΎΡΡ β€ 24 ΡΠ°ΡΠ° ΠΈ CHA2DS2-VASc score = 0 ΠΏΡΠΈ ΠΌΡΠΆΠ΅ ΠΈΠ»ΠΈ 1 ΠΏΡΠΈ ΠΆΠ΅Π½ΠΈ). ΠΡΠ΅ΡΡΠ°Π²Π° ΠΏΡΡΠ²ΠΈΡΠ΅ 6 ΡΠ°ΡΠ° Π½Π° Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½Π΅ΡΠΎ ΠΊΠ°ΡΠΎ Π²ΡΠ΅ΠΌΠ΅Π²ΠΈΡ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π», Π΄Π΅ΡΠΈΠ½ΠΈΡΠ°Ρ ΠΏΠΎ-Π½ΠΈΡΡΠΊ ΠΏΠ΅ΡΠΈΠΏΡΠΎΡΠ΅Π΄ΡΡΠ΅Π½ ΡΡΠΎΠΌΠ±ΠΎΠ΅ΠΌΠ±ΠΎΠ»ΠΈΡΠ΅Π½ ΡΠΈΡΠΊ. ΠΡΠ΅ΡΡΠ°Π²Π° Π²ΡΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π·Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ½ΠΎ ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ Π½Π° Π½ΡΠΊΠΎΠΈ Ρ
Π΅ΠΌΠΎΡΡΠ°Π·Π½ΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΠΎΡΠ²ΡΠ΄ Ρ
Π΅ΠΌΠΎΡΡΠ°Π·Π½Π°ΡΠ° ΠΎΡΠ΅Π½ΠΊΠ°, Π° ΠΈΠΌΠ΅Π½Π½ΠΎ Π²ΡΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ Π·Π° ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΈΡ ΠΈΠ·ΡΠ²Π°ΡΠ° Π½Π° ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΏΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅ ΡΡΠ΅Π· ΠΏΠ»Π°Π·ΠΌΠ΅Π½Π° Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡ Π½Π° ΠΏΠ»Π°Π·ΠΌΠΈΠ½ΠΎΠ³Π΅Π½ ΠΈ ΠΏΠ»Π°Π·ΠΌΠ΅Π½ΠΈ Π½ΠΈΠ²Π° Π½Π° t-PA ΠΈ Π½Π° Π½Π΅Π³ΠΎΠ²ΠΎΡΠΎ ΡΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠ΅ ΠΈΡΡ
Π΅ΠΌΠΈΡΠ΅Π½ ΠΌΠΎΠ·ΡΡΠ΅Π½ ΠΈΠ½ΡΡΠ»Ρ ΡΡΠ΅Π· ΠΏΠ»Π°Π·ΠΌΠ΅Π½ΠΈ Π½ΠΈΠ²Π° Π½Π° TF, FVIII ΠΈ Π²ΠΈΡΡΠΎΠ½Π΅ΠΊΡΠΈΠ½
Dynamics of oxidative status in paients with paroxysmal atrial fibrillation.// ΠΠΈΠ½Π°ΠΌΠΈΠΊΠ° Π² ΠΎΠΊΡΠΈΠ΄Π°ΡΠΈΠ²Π½ΠΈΡ ΡΡΠ°ΡΡΡ ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΏΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅.
[EN] Oxidative status in atrial fibrillation (AF) was analyzed mainly in patients with persistent or permanent type of the arrhythmia. Data on paroxysmal AF are scarce that gives us ground to specify the aim of the dissertation: to investigate the oxidative status in patients with paroxysmal AF and monitor its changes after sinus rhythm restoration. For that reason prooxidant and antioxidant system was studied in dynamics: during the episode of AF, 24 hours and 28 days after the rhythm disorder was terminated. Ten markers were measured by colourimetric enzymatic essay and atomic absorbtion spectrometry: levels of malondialdehyde and glutathione in plasma and erythrocites, activity of superoxide dismutase, catalase, glutathione peroxidase, glucose-6-phosphate dehydrogenase, ceruloplasmin and serum levels of copper. The results are original in their character. For the first time oxidative stress, result of enhanced prooxidant precesses and decreased antioxidant defence system, were established still in the early hours (up to the 24th hour) of paroxysmal atrial fibrillation; the oxidative balance recovered slowly after sinus rhythm restoration β till the 28th day after tha arrhythmia termination. For the first time copper deficiency was established during episode of paroxysmal AF, most probably closely related with the initiating mechanisms of the arrhythmia. Six markers appeared to be predictive for the AF appearance and precise mathematical models were created to calculate the possibility of the disorder development. New approach of antioxidant treatment in paroxysmal AF was suggested.[BG] ΠΠΊΡΠΈΠ΄Π°ΡΠΈΠ²Π½ΠΈΡΡ ΡΡΠ°ΡΡΡ ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΠΏΡΠ΅Π΄ΡΡΡΠ΄Π½ΠΎ ΠΌΡΠΆΠ΄Π΅Π½Π΅ (ΠΠ) Π΅ Π°Π½Π°Π»ΠΈΠ·ΠΈΡΠ°Π½ ΠΏΡΠ΅Π΄ΠΈΠΌΠ½ΠΎ ΠΏΡΠΈ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΠ°ΡΠΎ ΠΈ ΠΏΠ΅ΡΠΌΠ°Π½Π΅Π½ΡΠ½ΠΎ ΠΠ. Π’ΠΎΠ²Π° ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈ ΡΠ΅Π»ΡΠ° Π½Π° Π½Π°ΡΡΠΎΡΡΠΈΡ Π΄ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΎΠ½Π΅Π½ ΡΡΡΠ΄: Π΄Π° ΡΠ΅ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π° ΠΎΠΊΡΠΈΠ΄Π°ΡΠΈΠ²Π½ΠΈΡ ΡΡΠ°ΡΡΡ ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΠ ΠΈ ΡΠ΅ ΠΏΡΠΎΡΠ»Π΅Π΄ΡΡ ΠΏΡΠΎΠΌΠ΅Π½ΠΈΡΠ΅ Π² Π½Π΅Π³ΠΎ ΡΠ»Π΅Π΄ Π²ΡΠ·ΡΡΠ°Π½ΠΎΠ²ΡΠ²Π°Π½Π΅ Π½Π° ΡΠΈΠ½ΡΡΠΎΠ² ΡΠΈΡΡΠΌ. ΠΡΠΎΡΡΠΈ ΡΠ΅ ΡΡΡΡΠΎΡΠ½ΠΈΠ΅ΡΠΎ Π½Π° ΠΏΡΠΎΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½Π° ΠΈ Π°Π½ΡΠΈΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½Π° ΡΠΈΡΡΠ΅ΠΌΠ° ΠΏΠΎ Π²ΡΠ΅ΠΌΠ΅ Π½Π° ΠΠ, 24 ΡΠ°ΡΠ° ΠΈ 28 Π΄Π½ΠΈ ΡΠ»Π΅Π΄ Π²ΡΠ·ΡΡΠ°Π½ΠΎΠ²ΡΠ²Π°Π½Π΅ Π½Π° ΡΠΈΠ½ΡΡΠΎΠ² ΡΠΈΡΡΠΌ. Π§ΡΠ΅Π· ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΎΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅Π½ ΠΌΠ΅ΡΠΎΠ΄ ΠΈ Π΄ΠΈΡΠ΅ΠΊΡΠ½Π° ΠΏΠ»Π°ΠΌΡΠΊΠΎΠ²Π° Π°ΡΠΎΠΌΠ½ΠΎΠ°Π±ΡΠΎΡΠ±ΡΠΈΠΎΠ½Π½Π° ΠΏΡΠΎΡΠ΅Π΄ΡΡΠ° Π±ΡΡ
Π° ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈ Π΅Π΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ Π΄Π΅ΡΠ΅Ρ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ: Π½ΠΈΠ²Π° Π½Π° ΠΌΠ°Π»ΠΎΠ½Π΄ΠΈΠ°Π»Π΄Π΅Ρ
ΠΈΠ΄ ΠΈ Π³Π»ΡΡΠ°ΡΠΈΠΎΠ½ Π² ΠΏΠ»Π°Π·ΠΌΠ° ΠΈ Π΅ΡΠΈΡΡΠΎΡΠΈΡΠΈ, Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡ Π½Π° ΡΡΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄ Π΄ΠΈΡΠΌΡΡΠ°Π·Π°, ΠΊΠ°ΡΠ°Π»Π°Π·Π°, Π³Π»ΡΡΠ°ΡΠΈΠΎΠ½ ΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°Π·Π°, Π³Π»ΡΠΊΠΎΠ·ΠΎ-6-ΡΠΎΡΡΠ°Ρ Π΄Π΅Ρ
ΠΈΠ΄ΡΠΎΠ³Π΅Π½Π°Π·Π°, ΡΠ΅ΡΡΠ»ΠΎΠΏΠ»Π°Π·ΠΌΠΈΠ½ ΠΈ ΡΠ΅ΡΡΠΌΠ΅Π½ ΠΌΠ΅Π΄. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈ ΠΏΡΠΈΡΠ΅ΠΆΠ°Π²Π°Ρ ΠΈΠ·ΡΡΠ»ΠΎ ΠΎΡΠΈΠ³ΠΈΠ½Π°Π»Π΅Π½ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ. ΠΠ° ΠΏΡΡΠ²ΠΈ ΠΏΡΡ ΠΏΡΠΈ ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΠ ΡΠ΅ ΡΡΡΠ°Π½ΠΎΠ²ΡΠ²Π° ΠΎΠΊΡΠΈΠ΄Π°ΡΠΈΠ²Π΅Π½ ΡΡΡΠ΅Ρ ΠΎΡΠ΅ Π΄ΠΎ 24-Ρ ΡΠ°Ρ ΡΠ»Π΅Π΄ ΠΊΠ»ΠΈΠ½ΠΈΡΠ½Π°ΡΠ° ΠΌΡ ΠΈΠ·ΡΠ²Π°, ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ Π½Π° Π·Π°ΡΠΈΠ»Π΅Π½ΠΈ ΠΏΡΠΎΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½ΠΈ ΠΏΡΠΎΡΠ΅ΡΠΈ ΠΈ ΠΏΠΎΠ½ΠΈΠΆΠ΅Π½ΠΈ Π°Π½ΡΠΈΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½ΠΈ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΈ ΠΈ Π²ΡΠ·ΡΡΠ°Π½ΠΎΠ²ΡΠ²Π°Π½Π΅ Π½Π° ΠΎΠΊΡΠΈΠ΄Π°ΡΠΈΠ²Π½ΠΈΡ Π±Π°Π»Π°Π½Ρ Π±Π°Π²Π½ΠΎ Π²ΡΠ² Π²ΡΠ΅ΠΌΠ΅ΡΠΎ β Π΄ΠΎ Π΄Π²Π°Π΄Π΅ΡΠ΅Ρ ΠΈ ΠΎΡΠ΅ΠΌ Π΄Π½ΠΈ ΡΠ»Π΅Π΄ Π΅ΠΏΠΈΠ·ΠΎΠ΄Π° Π½Π° ΠΠ. ΠΠ° ΠΏΡΡΠ²ΠΈ ΠΏΡΡ Π΅ ΠΏΠΎΠΊΠ°Π·Π°Π½ ΠΌΠ΅Π΄Π΅Π½ Π΄Π΅ΡΠΈΡΠΈΡ ΠΏΡΠΈ ΠΈΠ·ΡΠ²Π°ΡΠ° Π½Π° Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½Π΅ΡΠΎ ΠΈ Π΅ ΠΏΠΎΡΡΡΡΠ΅Π½Π° Π²ΡΡΠ·ΠΊΠ° Ρ ΠΈΠ½ΠΈΡΠΈΠΈΡΠ°ΡΠΈΡΠ΅ Π³ΠΎ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΈ. Π£ΡΡΠ°Π½ΠΎΠ²Π΅Π½ΠΎ Π΅, ΡΠ΅ ΡΠ΅ΡΡ ΠΎΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈΡΠ΅ ΡΠ° ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΈΠ²Π½ΠΈ Π·Π° ΠΈΠ·ΡΠ²Π°ΡΠ° Π½Π° ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌΠ°Π»Π½ΠΎ ΠΠ ΠΈ ΡΠ° ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π΅Π½ΠΈ ΠΌΠ°ΡΠ΅ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈ ΠΌΠΎΠ΄Π΅Π»ΠΈ Π·Π° ΠΈΠ·ΡΠΈΡΠ»ΡΠ²Π°Π½Π΅ Π²Π΅ΡΠΎΡΡΠ½ΠΎΡΡΡΠ° Π·Π° ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π° Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½Π΅ΡΠΎ. ΠΠ°ΠΏΡΠ°Π²Π΅Π½ΠΎ Π΅ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½ΠΈΠ΅ Π·Π° Π½ΠΎΠ² ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ ΠΏΡΠΈ Π°Π½ΡΠΈΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½ΠΎΡΠΎ Π»Π΅ΡΠ΅Π½ΠΈΠ΅
ECG Changes in Patients with Hypothermia
Introduction:Β Hypothermia is defined as a condition, in which the body core temperature is below 35Β°C. The most common causes are due to environmental circumstances, e.g. exposure to cold weather. Non-environmental causes are uncommon, but also should be taken into consideration, e.g. hypothermia with diabetic ketoacidosis. Our aim is to draw attention to the changes in the electrocardiogram (ECG), which are characteristic for the patients with hypothermia.Materials and Methods:Β We conducted a literature review using Pub Med, Google Scholar, and MedlinePlus databases from 1984 until March 2016. We used keywords like hypothermia, ECG in hypothermia, cases of hypothermia and accidental hypothermia. We included reviews published in journals with evidence-based medical publications.Results:Β In a normal 12-lead ECG obtained from a hypothermic patient, a broad spectrum of changes can be observed, they could be confusing and necessitating some extra tests and exams. Some of them may seem similar to those found in acute coronary ischaemia and pericarditis. The T wave can show varied differences, e.g. the T wave can be negative in lead V2-V6. PR, QT and QRS intervals can be differently prolonged. Most specific for hypothermia is the J point elevation, also called Osborne wave, an extra elevation after the QRS complex. The wave correlates directly with the body temperature, the amplitude increases with the decreasing temperature.Hypothermic patients may present with different atrial or ventricle rhythm disorders. Bradyarrhythmias are typical of those patients incl. atrial fibrillation with slow ventricular response, varying degrees of AV block, etc.All ECG changes disappear after rewarming the patients.Conclusion:Β Hypothermia often results in ECG changes, and should be recognised by the emergency doctors, because they have a diagnostic and prognostic importance. The special findings should be detected as early as possible to provide patients the correct treatment
Correlation between oral hygiene and health status of patients with cardiovascular diseases
Introduction: There are a number of studies in the scientific literature about the influence of endodontic pathology on the health status of patients with chronic non-communicable diseases. Diabetics have long been known to suffer from inflammatory periodontal diseases, caries and its complications. There are data that patients with cardiovascular disease also have more frequent oral pathology. More often dentists find a link between patients' dental problems and their chronic illnesses, but there are few studies on the correlation between oral hygiene and the health status of patients with cardiovascular disease.Aim: The aim of this article is to assess whether there is and what the correlation between oral hygiene and health status in patients with cardiovascular diseases is, in order to prevent their dental or general health.Materials and Methods: Forty patients with cardiovascular diseases were examined. The study used: a documentary method (patients' medical documents), a survey method, and a clinical dental examination.Results: During the dental examination we found a significant correlation between bleeding gums and the presence of cardiovascular diseases. In smokers, oral hygiene and brushing teeth were very neglected. Survey data showed that less frequent brushing of teeth is more common among men, older patients and those who are overweight. Patients with lower body weight who followed a diet and healthy eating also had better oral hygiene. A total of 61% of the patients reported a visit to their dentist in the last year. Most respondents (72%) had at least one dental problem, but only 12% received adequate information from their dentist about their oral health.Conclusion: Our results confirm the positive correlation between oral hygiene and the health status of patients with cardiovascular diseases, therefore it is important for dentists to train more actively such patients to improve their oral hygiene, which would improve their overall health